Mid-term treatment-related cognitive sequelae in glioma patients.

Principally it has to be considered that the mere lack of significant differences in primary and secondary outcome measures in this rather small and heterogeneous sample does not exclude the presence of subtle changes that may be significant in larger populations.

also in 13,097 other papers